» Articles » PMID: 21896552

Tryptophan in Alcoholism Treatment I: Kynurenine Metabolites Inhibit the Rat Liver Mitochondrial Low Km Aldehyde Dehydrogenase Activity, Elevate Blood Acetaldehyde Concentration and Induce Aversion to Alcohol

Overview
Journal Alcohol Alcohol
Specialty Psychiatry
Date 2011 Sep 8
PMID 21896552
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The aims were to provide proofs of mechanism and principle by establishing the ability of kynurenine metabolites to inhibit the liver mitochondrial low K(m) aldehyde dehydrogenase (ALDH) activity after administration and in vivo, and to induce aversion to alcohol.

Methods: Kynurenic acid (KA), 3-hydroxykynurenine (3-HK) and 3-hydroxyanthranilic acid (3-HAA) were administered to normal male Wistar rats and ALDH activity was determined both in vitro in liver homogenates and in vivo (by measuring blood acetaldehyde following ethanol administration). Alcohol consumption was studied in an aversion model in rats and in alcohol-preferring C57 mice.

Results: ALDH activity was significantly inhibited by all three metabolites by doses as small as 1 mg/kg body wt. Blood acetaldehyde accumulation after ethanol administration was strongly elevated by KA and 3-HK and to a lesser extent by 3-HAA. All three metabolites induced aversion to alcohol in rats and decreased alcohol preference in mice.

Conclusions: The above kynurenine metabolites of tryptophan induce aversion to alcohol by inhibiting ALDH activity. An intellectual property covering the use of 3-HK and 3-HAA and derivatives thereof in the treatment of alcoholism by aversion awaits further development.

Citing Articles

Alcohol Use Disorder and the Gut-Brain Axis: A Narrative Review of the Role of Gut Microbiota and Implications for Treatment.

Shukla S, Hsu C Microorganisms. 2025; 13(1).

PMID: 39858835 PMC: 11767426. DOI: 10.3390/microorganisms13010067.


Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61-8048 after chronic intermittent ethanol in mice.

Gil de Biedma-Elduayen L, Gimenez-Gomez P, Morales-Puerto N, Vidal R, Nunez-de la Calle C, Gutierrez-Lopez M Br J Pharmacol. 2022; 179(14):3711-3726.

PMID: 35189673 PMC: 9314579. DOI: 10.1111/bph.15825.


Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms.

Leclercq S, Schwarz M, Delzenne N, Starkel P, de Timary P Transl Psychiatry. 2021; 11(1):503.

PMID: 34599147 PMC: 8486842. DOI: 10.1038/s41398-021-01610-5.


Changes in brain kynurenine levels gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice.

Gimenez-Gomez P, Perez-Hernandez M, OShea E, Caso J, Martin-Hernandez D, Cervera L FASEB J. 2019; 33(11):12900-12914.

PMID: 31509716 PMC: 6902706. DOI: 10.1096/fj.201900491RR.


Reply to: kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms?.

Vengeliene V Psychopharmacology (Berl). 2016; 234(1):167-168.

PMID: 27896378 DOI: 10.1007/s00213-016-4489-1.


References
1.
Lapin I . Antagonism of kynurenic acid to anxiogens in mice. Life Sci. 1998; 63(15):PL231-6. DOI: 10.1016/s0024-3205(98)00404-4. View

2.
Tottmar S, Pettersson H, Kiessling K . The subcellular distribution and properties of aldehyde dehydrogenases in rat liver. Biochem J. 1973; 135(4):577-86. PMC: 1165872. DOI: 10.1042/bj1350577a. View

3.
Badawy A . Tryptophan metabolism in alcoholism. Nutr Res Rev. 2008; 15(1):123-52. DOI: 10.1079/NRR200133. View

4.
MacKay G, Forrest C, Stoy N, Christofides J, Egerton M, Stone T . Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol. 2006; 13(1):30-42. DOI: 10.1111/j.1468-1331.2006.01220.x. View

5.
Lapin I, Politi V . Antiethanol effects of indol-3-ylpyruvic acid in mice. Alcohol Alcohol. 1994; 29(3):265-8. View